The latest high-end hemodynamics device
for checkup, healthcare centers and
Our new device marks the next generation of intelligent and versatile cardiovascular management for all patient populations.
The future of technology in handling hypertension
Hypertension is a risk factor (not a disease), it shortens the life span. It afflicts approximately 33% of world adult population. Current antihypertensive therapy outcomes are poor, normally less than 35%. But with HOTMAN system, it may increase to over 90%. Incorrect selection of antihypertension drugs has medical consequences and also side effects, which affect duration of therapy, its cost, the quality of life as well as longevity. It thus impacts negatively the economy and increase the health care cost.
To understand more, please visits